Tempus AI, Inc. (NASDAQ: TEM) represents a critical nexus in the modern biotechnology landscape, operating at the intersection of generative artificial intelligence, next-generation genomic sequencing, and precision medicine. By systematically aggregating and harmonizing one of the world's largest libraries of multimodal healthcare data—surpassing 500 petabytes of clinical, molecular, and imaging records—Tempus has entrenched itself as an indispensable foundational layer for the global pharmaceutical industry. The enterprise operates through a highly synergistic, dual-engine business model. The physical Diagnostics segment acts as a data-ingestion funnel, processing oncology, hereditary, and minimal residual disease (MRD) assays. The resulting longitudinal patient data is subsequently anonymized and transferred to the high-margin Data and Applica ...